Posted on 02/20/2020 10:33:28 AM PST by TigerClaws
A Texas-based genetic engineering company has finished developing a coronavirus vaccine, according to new reports.
Scientists at Greffex Inc. which has a corporate headquarters in Houston and a laboratory in Aurora, Colorado completed the vaccine this week, company president and CEO John Price told the Houston Business Journal.
Now the vaccine will move to animal testing by the necessary government agencies the FDA in the US and similar regulatory bodies in China and other heavily affected countries, according to the report.
For safety reasons, Greffex did not use a living or killed virus to form the vaccine, according to Price. Instead, adenovirus-based vector vaccines, which are widely employed against various infectious diseases or cancers, were used, the report noted.
The trick in making a vaccine is can you scale the vaccine that youve made to be able to make a certain number of doses, can you test that vaccine quickly and efficiently and then can you get it into patients, Price told local outlet KHOU 11. And thats where we have an edge as well on the other companies that are out there.
The vaccine is the product of an $18.9 million contract Greffex received in September 2019 from the National Institute of Healths National Institute for Allergy and Infectious Diseases, aimed at fighting infectious threats, the Business Journal reported.
If the vaccine wins government approval, Greffex will give it away for free to the hardest-hit countries, Price said.
More than 2,100 people have died as a result of the COVID-19 outbreak, with all but 11 of those deaths in mainland China. Worldwide, more than 75,700 people have been infected.
(Excerpt) Read more at nypost.com ...
$18.9 million would not include the cost to receive FDA approva.l
Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, according to a new study by a team including researchers from Johns Hopkins Bloomberg School of Public Health...The $19 million median figure represents less than one percent of the average total cost of developing a new drug, which in recent years has been estimated at between $2 to $3 billion..for some indications, such as rare incurable diseases, the FDA will accept much smaller, shorter trialshttps://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html
Is this is not usually mentioned when liberals cite the cost of domestically produced drugs?
There’s a video on this page of the CEO:
I’d say it’s a scam using the “too good to be true” test. Private companies can attract sucker investors, too.
DATE TIME DAY CASES 02/17/20 23:43 MON 31 02/18/20 09:23 TUE 31 02/18/20 15:23 TUE 31 02/18/20 18:13 TUE 31 02/18/20 20:33 TUE 31 02/18/20 23:03 TUE 31 02/19/20 08:43 WED 31 02/19/20 15:53 WED 31 02/19/20 20:03 WED 82 02/19/20 23:33 WED 82 02/19/20 23:53 WED 82 02/20/20 09:33 THU 104 02/20/20 16:13 THU 104 02/20/20 18:33 THU 156
Word is those who got the SARS vaccine are getting hit with coronavirus harder than those who didn’t get it.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.